Sequenom, New England Biolabs Ink Deal for Epigenetics Technology
April 06, 2011
Sequenom, New England Biolabs Ink Deal for Epigenetics Technology
In conjunction with the agreement, the two companies launched a kit for the discovery and analysis of differentially methylated regions in biological samples.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.